***Please note that, in order to access these course materials, you must create a user profile if you do not already have one. Your profile one ScientiaCME's website is unrelated to your profile on North American Thrombosis Forum's (NATF's) website.***
The content of this online activity was presented originally at a live event. It is divided into two videos. Learners must view both videos in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit.
The North American Thrombosis Forum's (NATF’s) “2020 NATF Online Summit on Women’s Cardiovascular Health” focuses on the unique risks and challenges that women face regarding their cardiovascular health, with a particular focus on thrombotic illnesses such as myocardial infarction (MI), stroke, and venous thromboembolism (VTE). It also explores how biological changes across a woman’s lifespan can increase cardiovascular event risk and will further address best practices for managing this risk.
Hospitalists and physicians, pharmacists, nurses, physician assistants, nurse practitioners, and surgeons who specialize in cardiovascular medicine, endocrinology, family practice, internal medicine, gynecology, or obstetrics.
Participation in this activity is made possible, free of charge, with the support of Cordis.
Release Date: January 13, 2021 -- Expiration Date: July 13, 2022
Faculty: Multiple Faculty,
Introduction - Gregory Piazza, MD, MS
Acute Coronary Syndromes in Women: A Gender-Focused Approach to Diagnosis and Treatment - Margo Minissian, PhD
When Heart Attacks Don’t Play by the Rules: The Challenge of Non-Atherosclerotic Coronary Disease - Malissa Wood, MD
An Enemy in Plain Sight: Thrombosis and Hypercoagulable States in Young Women - Gregory Piazza, MD, MS
Structural Heart Disease in Pregnant Women: Ensuring a Safe Pregnancy for Mother and Baby - Anne Marie Valente, MD
Understanding Why Stroke Presents a Disproportionate Cardiovascular Burden in Women - Kathryn Rexrode, MD
Panel Discussion: Answers to Commonly Asked Questions on Women's Cardivacular Health
-The following presenters/moderators:
Gregory Piazza, MD, MS
Kathryn Rexrode, MD, MPH
Anne Marie Valente, MD
Kathryn Mikkelsen, MBA (NATF Executive Director), moderator
Malissa Wood, MD
Margo B. Minissian, PhD, ACNP
By the end of the session the participant will be able to:
ACCME Activity #201762751
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of ScientiaCME and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: ScientiaCME designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physicians: For maintenance of certification (MOC) credit, you must enter your board certification ID # and birth date correctly. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC credit for this activity.
Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.
Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire group of presentations and complete the course evaluation to receive continuing pharmacy education credit. ACPE UAN: 0574-9999-21-002-H01-P.
This is an Application (A)-type activity.
Pharmacists: You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.
The CPE statements of credit contain information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.
Margo B. Minissian, PhD, ACNP, NEABC, FAHA, FNLA, Research Scientist, Executive Director, Brawerman Institute, Nursing Education, Innovation, Performance Improvement Research Director, Postpartum Heart Health Program Smidt Heart Institute Cedars-Sinai Medical Center discloses consultant and medical advisory board compensation from Amgen.
Gregory Piazza, MD, MS, Associate Professor of Medicine, Harvard Medical School; Staff Physician, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, discloses grant/research support from BMS, Portola, BTG/EKOS, Janssen, Bayer, and Daiichi-Sankyo and is a consultant for Pfizer, Amgen, and Thrombolex.
Individuals with no conflicts of interest to disclose:
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.